NIKKEI 225
38,133.54 +171.74 (+0.45%) HANG SENG
16,469.29 +217.45 (+1.34%) CRUDE OIL
82.78 +0.09 (+0.11%) GOLD FUTURES
2,390.00 +1.60 (+0.07%) DOW
37,753.31 -45.66 (-0.12%) Bitcoin GBP
49,461.62 -2,028.83 (-3.94%)
ResMed Inc. (RMD)
After hours:
| Previous close | 184.86 |
| Open | 182.00 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1000 |
| Day's range | 172.19 - 183.40 |
| 52-week range | 132.24 - 243.52 |
| Volume | |
| Avg. volume | 1,030,470 |
| Market cap | 25.568B |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | 28.83 |
| EPS (TTM) | 6.03 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | 1.92 (1.10%) |
| Ex-dividend date | 07 Feb 2024 |
| 1y target est | 202.68 |
Investor's Business DailyEli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test
Eli Lilly stock popped Wednesday after the company's weight-loss drug significantly reduced nighttime sleep apnea events.
GlobeNewswireResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2024 on Thursday, April 25, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: • Location:http://investor.resmed.com • Da
Zacks5 Medical Product Stocks to Buy Amid Industry Challenges
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. SYK, RMD, ZBH, PODD and LNTH are well-poised to gain from the favorable factors.
